DarioHealth Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by DarioHealth Corp. (DRIO) on February 24, 2023, covering events occurring on February 22 and February 23, 2023. The filing primarily addresses corporate governance changes regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel appointments and does not contain financial performance data.
Material Changes
The material change reported is the expansion of the Board of Directors by one seat. Jon Kaplan was appointed as a new member of the Board, effective immediately on February 22, 2023.
Management Commentary and Governance Details
- New Director Profile: Jon Kaplan, 55, brings extensive experience in healthcare consulting and advising. He has served as a Senior Partner and Managing Director at Boston Consulting Group (BCG) since 2007, previously leading BCG's healthcare services practice.
- Prior Experience: Mr. Kaplan previously served on the Board of Directors and audit committee of Quorum Health Corporation (2018-2020) and held advisory roles at Livongo, Transcarent, Circulation, and Picwell.
- Compensation: Mr. Kaplan will receive the same fees as the Company's other non-executive directors. No special arrangements or understandings regarding his election were disclosed.
- Public Announcement: A press release announcing the appointment was issued on February 23, 2023, and is included as Exhibit 99.1.
Investor Verification Checklist
- Verify the official press release (Exhibit 99.1) for additional details on Mr. Kaplan's strategic role.
- Review the Company's most recent 10-K or 10-Q filings for current financial performance, as this 8-K contains no financial data.
- Confirm the updated Board composition on the Company's investor relations website.